Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01503307 · ClinicalTrials.gov registry record
Parenting After Infant Congenital Heart Defect Diagnosis
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 23
- Enrollment target
NCT01503307: Completed study, sponsored by Medical College of Wisconsin.
NCT01503307 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01503307 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn about parents' experiences following diagnosis of a fetal/neonatal Congenital Heart Defect (CHD). Nurses, physicians, and other health-care clinicians will benefit from an improved understanding of what the diagnosis means to parents and what they expect concerning the infant, being a parent, and caregiving tasks and responsibilities. The investigators expect that the knowledge gained will increase clinicians' ability to respond to parents' needs.
Primary Outcome
Qualitative analysis of interviews.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-01 |
| Est. Completion | 2016-07 |
What the finished NCT01503307 record still lists
NCT01503307 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01503307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01503307 about?
NCT01503307 is a clinical study titled "Parenting After Infant Congenital Heart Defect Diagnosis". The purpose of this research study is to learn about parents' experiences following diagnosis of a fetal/neonatal Congenital Heart Defect (CHD). Nurses, physicians, and other health-care clinicians will benefit from an improved understanding of what the diagnosis means to parents and what they expec...
What is the current status of trial NCT01503307?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2009-01. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT01503307?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia